A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors: a Single Arm Trial.
Status: Recruiting
Location: See location...
Intervention Type: Combination product
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
The purpose is to explore the efficacy and safety of the SYSUCC-RMS regimen for pediatric RMS patients and to explore the impact of concurrent radiotherapy and chemotherapy on the survival rate of low-risk, medium risk, high-risk, and extremely high-risk patients in children.
Eligibility
Participation Requirements
Sex: All
Maximum Age: 18
Healthy Volunteers: f
View:
• 0 years \< age \< 18 years old, regardless of gender;
• Tumor patients diagnosed by histopathology or bone marrow cytology;
• Patients are treated for the first time;
• ECoG score ≤ 2;
• The expected survival time is more than 8 months;
• Patient's parent or guardian signs informed consent.
Locations
Other Locations
China
Suying Lu
RECRUITING
Guangzhou
Contact Information
Primary
Suying Lu
lusy@sysucc.org.cn
+020-87342460
Time Frame
Start Date: 2017-01-30
Estimated Completion Date: 2029-12
Participants
Target number of participants: 300
Treatments
Other: Low risk
Other: Moderate risk
Other: High risk
Other: Very high risk
Related Therapeutic Areas
Sponsors
Leads: Yizhuo Zhang